| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 哈药集团股份有限公司是一家医药行业类公司.本公司的主要产品有:青霉素钾盐、头孢唑林钠、头孢噻肟钠、青霉素、凯塞欣、阿莫西林、严迪片、护彤、高钙片、钙加锌口服液、双黄连粉针、丹参粉针、注射用双黄连、布洛芬颗粒、逍遥丸、丹佛胃尔康、牛黄降压片、六味地黄丸及纯中纯无菌纯净水等.公司是全国医药行业最早的上市公司之一,公司产品包括西药、中药和保健品等88个品种被认定为高新技术产品."哈药"商标已被国家工商行政管理总局商标局认定为中国驰名商标,是国内最具价值的医药品牌之一。 | ||||||||||||||||||||||||
| Main Business | 公司医药研发与制造业务涵盖化学原料药、化学制剂、生物制剂、中药、保健品等产业领域，公司拥有1802个药品批文和100个保健品批文，产品聚焦大健康、抗 感染、慢病、消化、呼吸等治疗领域。 | ||||||||||||||||||||||||
| Legal Representative | 芦传有 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 孟晓东 | ||||||||||||||||||||||||
| Solicitors | 北京市共和律师事务所 | ||||||||||||||||||||||||
| Auditors | 北京兴华会计师事务所有限责任公司 | ||||||||||||||||||||||||
| Tel No | 0451-51870077 | ||||||||||||||||||||||||
| Fax No | 0451-51870277 | ||||||||||||||||||||||||
| Website | www.hayao.com | ||||||||||||||||||||||||
| master@hayao.com;hybs@hayao.com；maky@hayao.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 29/06/1993 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.160 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 1.874 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 7.631B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |